Compare Lennar Corporation (LEN) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lennar Corporation vs Sanofi SA — how do they compare? Lennar Corporation trades at $87.46 (market cap $21.05B), while Sanofi SA trades at $43.56 (market cap $104.30B). The key difference: Sanofi SA is far larger — about 5× Lennar Corporation's market cap, and Sanofi SA pays the higher dividend (5.55%). Which is the better fit depends on your goals.
| LEN | SNY | |
|---|---|---|
Market Cap | $21.05B | $104.30B |
Sector | Consumer Cyclical | Health |
52-Week High | $142.40 | $52.34 |
52-Week Low | $81.84 | $41.33 |
Enterprise Value | $24.93B | $124.19B |
Dividend Yield | 2.28% | 5.55% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lennar Corporation
Lennar is the second-largest public homebuilder in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Read more on LEN →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
